Causative and susceptibility genes for Alzheimer's disease: a review

被引:216
作者
Rocchi, A
Pellegrini, S
Siciliano, G
Murri, L
机构
[1] Univ Pisa, Sch Med, Dept Neurosci, Neurol Clin, I-56126 Pisa, Italy
[2] Univ Pisa, Sch Med, Dept Expt Pathol & Med Biotechnol, I-56127 Pisa, Italy
关键词
amyloid precursor protein; presenilin; apolipoprotein E; genetic risk factors; association studies; polymorphism; dementia;
D O I
10.1016/S0361-9230(03)00067-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) is the most common type of dementia in the elderly population. Three genes have been identified as responsible for the rare early-onset familial form of the disease: the amyloid precursor protein (APP) gene, the presenilin 1 (PSEN1) gene and the presenilin 2 (PSEN2) gene. Mutations in these genes, however, account for less than 5% of the total number of AD cases. The remaining 95% of AD patients are mostly sporadic late-onset cases, with a complex aetiology due to interactions between environmental conditions and genetic features of the individual. In this paper, we review the most important genes supposed to be involved in the pathogenesis of AD, known as susceptibility genes, in an attempt to provide a comprehensive picture of what is known about the genetic mechanisms underlying the onset and progression of AD. Hypotheses about the role of each gene in the pathogenic pathway are discussed, taking into account the functions and molecular features, if known, of the coded protein. A major susceptibility gene, the apolipoprotein E (APOE) gene, found to be associated with sporadic late-onset AD cases and the only one, whose role in AD has been confirmed in numerous studies, will be included in a specific chapter. As the results reported by association studies are conflicting, we conclude that a better understanding of the complex aetiology that underlies AD may be achieved likely through a multidisciplinary approach that combines clinical and neurophysiological characterization of AD subtypes and in vivo functional brain imaging studies with molecular investigations of genetic components. (C) 2003 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:1 / 24
页数:24
相关论文
共 302 条
[1]   ALPHA-1-ANTICHYMOTRYPSIN IS ASSOCIATED SOLELY WITH AMYLOID DEPOSITS CONTAINING THE BETA-PROTEIN - AMYLOID AND CELL LOCALIZATION OF ALPHA-1-ANTICHYMOTRYPSIN [J].
ABRAHAM, CR ;
SHIRAHAMA, T ;
POTTER, H .
NEUROBIOLOGY OF AGING, 1990, 11 (02) :123-129
[2]   IMMUNOCHEMICAL IDENTIFICATION OF THE SERINE PROTEASE INHIBITOR ALPHA-1-ANTICHYMOTRYPSIN IN THE BRAIN AMYLOID DEPOSITS OF ALZHEIMERS-DISEASE [J].
ABRAHAM, CR ;
SELKOE, DJ ;
POTTER, H .
CELL, 1988, 52 (04) :487-501
[3]   Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NFκB-dependent mechanism [J].
Akama, KT ;
Albanese, C ;
Pestell, RG ;
Van Eldik, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (10) :5795-5800
[4]   Angiotensin converting enzyme and endothelial nitric oxide synthase DNA polymorphisms and late onset Alzheimer's disease [J].
Alvarez, R ;
Alvarez, V ;
Lahoz, CH ;
Martínez, C ;
Peña, J ;
Sánchez, JM ;
Guisasola, LM ;
Salas-Puig, J ;
Moris, G ;
Vidal, JA ;
Ribacoba, R ;
Menes, BB ;
Uría, D ;
Coto, E .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 67 (06) :733-736
[5]   Association between an α2 macroglobulin DNA polymorphism and late-onset Alzheimer's disease [J].
Alvarez, V ;
Alvarez, R ;
Lahoz, CH ;
Martínez, C ;
Peña, J ;
Guisasola, LM ;
Salas-Puig, J ;
Morís, G ;
Uría, D ;
Menes, BB ;
Ribacoba, R ;
Vidal, JA ;
Sánchez, JM ;
Coto, E .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 264 (01) :48-50
[6]   The -491 TT apolipoprotein E promoter polymorphism is associated with reduced risk for sporadic Alzheimer's disease [J].
Alvarez-Arcaya, A ;
Combarros, O ;
Llorca, J ;
Sánchez-Guerra, M ;
Berciano, J ;
Fernández-Luna, JL .
NEUROSCIENCE LETTERS, 2001, 304 (03) :204-208
[7]   The renin angiotensin system and Alzheimer's disease [J].
Amouyel, P ;
Richard, F ;
Berr, C ;
David-Fromentin, I ;
Helbecque, N .
VASCULAR FACTORS IN ALZHEIMER'S DISEASE, 2000, 903 :437-441
[8]   A presenilin 1 mutation associated with familial frontotemporal dementia inhibits γ-secretase cleavage of APP and notch [J].
Amtul, Z ;
Lewis, PA ;
Piper, S ;
Crook, R ;
Baker, M ;
Findlay, K ;
Singleton, A ;
Hogg, M ;
Younkin, L ;
Younkin, SG ;
Hardy, J ;
Hutton, M ;
Boeve, BF ;
Tang-Wai, D ;
Golde, TE .
NEUROBIOLOGY OF DISEASE, 2002, 9 (02) :269-273
[9]   Unusual phenotypic alteration of β amyloid precursor protein (βAPP) maturation by a new Val-715→Met βAPP-770 mutation responsible for probable early-onset Alzheimer's disease [J].
Ancolio, K ;
Dumanchin, C ;
Barelli, H ;
Warter, JM ;
Brice, A ;
Campion, D ;
Frébourg, T ;
Checler, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) :4119-4124
[10]   Association study of three polymorphisms of TGF-β1 gene with Alzheimer's disease [J].
Araria-Goumidi, L ;
Lambert, JC ;
Mann, DMA ;
Lendon, C ;
Frigard, B ;
Iwatsubo, T ;
Cottel, D ;
Amouyel, P ;
Chartier-Harlin, MC .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2002, 73 (01) :62-64